COVID-19: Private equity and venture capital fund considerations | Practical Law

COVID-19: Private equity and venture capital fund considerations | Practical Law

The novel coronavirus disease 2019 (COVID-19) pandemic presents significant challenges for private equity and venture capital fund sponsors and investment managers – from additional risk disclosures being required, questions around fund sponsors’ ability to refer to track record generated in different circumstances – through to daily operational issues like the difficulty of generating a reliable fund net asset value where markets are disrupted, and the requirement to keep providing management services under difficult circumstances. This article discusses some of those challenges.

COVID-19: Private equity and venture capital fund considerations

Published on 23 Apr 2020Australia
The novel coronavirus disease 2019 (COVID-19) pandemic presents significant challenges for private equity and venture capital fund sponsors and investment managers – from additional risk disclosures being required, questions around fund sponsors’ ability to refer to track record generated in different circumstances – through to daily operational issues like the difficulty of generating a reliable fund net asset value where markets are disrupted, and the requirement to keep providing management services under difficult circumstances. This article discusses some of those challenges.